Hospira
From Wikipedia, the free encyclopedia
| Hospira, Inc. | |
 |
|
| Type | Public (NYSE: HSP) |
|---|---|
| Founded | Lake Forest, Illinois (May 3, 2004) |
| Headquarters | Lake Forest, Illinois, United States |
| Website | www.hospira.com |
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing and marketing products that help improve the productivity, safety and efficacy of patient care. With 70 years of service to the hospital industry, Hospira's portfolio includes one of the industry's broadest lines of generic acute-care injectables, which help address the high cost of proprietary pharmaceuticals; integrated solutions for medication management and infusion therapy; and the leading U.S. injectable contract manufacturing business. Headquartered north of Chicago in Lake Forest, Illinois, Hospira has approximately 16,000 employees and 19 manufacturing facilities worldwide. Hospira acquired Mayne Pharma (an Australian generics specialist oncology drug maker) February 2, 2007 at a reported A$2.6 billion making Hospira the biggest generic injectables company in the world.
[edit] History
Spun off from Abbott Laboratories on May 3, 2004.
[edit] Products
Some of the key products produced by Hospira:
[edit] External links
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
